SEC Form D · filed January 21, 2021
TITAN PHARMACEUTICALS INC
Location
SAN FRANCISCO, CA
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (15)
Katherine B. Devarney · SAN FRANCISCO, CAExec · DirectorM. D. Mcfarlane · SAN FRANCISCO, CADirectorMarc Rubin · SAN FRANCISCO, CAExecJoseph A. Akers · SAN FRANCISCO, CADirectorJames R. Mcnab, Jr · SAN FRANCISCO, CADirectorJonathan Huang · San Francisco, CAExec · DirectorM. D. Mcfarlane · SAN FRANCISCO, CADirectorKristor Gervat · New York, NYExecReid C. Covington · Key Largo, FLDirectorJames R. Mcnab, Jr · SAN FRANCISCO, CADirectorAlex Appleton · London, United KingdomDirectorMatthew Shaw · London, United KingdomExec · DirectorSarah Gow · London, United KingdomDirectorMaria Perrella · London, United KingdomExecPeter Wall · London, United KingdomDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗